The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
73689983 7368998 3 F 20100320 20160823 20100428 20160913 EXP US-ROCHE-699269 ROCHE 75.00 YR F Y 76.00000 KG 20160913 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
73689983 7368998 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) FREQUENCY:OVER 30-90 MINUTES ON DAY 1 AND 15.LAST DOSE OF PRIOR TO SAE:26 APRIL 2010(CYCLE1, DAY15) N 125085 10 MG/KG
73689983 7368998 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) N 125085 1546 MG
73689983 7368998 3 SS TEMSIROLIMUS TEMSIROLIMUS 1 Intravenous (not otherwise specified) FREQUENCY:OVER 30 MINUTES ON DAY 1,8,15 AND22.LAST DOSE OF PRIOR TO SAE: 03 MAY 2010 (CYCLE1,DAY22) N 0 100 MG
73689983 7368998 4 SS TEMSIROLIMUS TEMSIROLIMUS 1 Intravenous (not otherwise specified) N 0 80 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
73689983 7368998 1 Ovarian neoplasm
73689983 7368998 3 Ovarian neoplasm

Outcome of event

Event ID CASEID OUTC COD
73689983 7368998 HO
73689983 7368998 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
73689983 7368998 Arthralgia
73689983 7368998 Dehydration
73689983 7368998 Fatigue
73689983 7368998 Hypoacusis
73689983 7368998 Hypokalaemia
73689983 7368998 Hypophosphataemia
73689983 7368998 Mucosal inflammation
73689983 7368998 Pulmonary haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found